MARKET

ASND

ASND

Ascendis Pharma
NASDAQ
228.03
+0.16
+0.07%
Closed 19:30 10/05 EDT
OPEN
229.66
PREV CLOSE
227.87
HIGH
230.73
LOW
226.84
VOLUME
783.23K
TURNOVER
0
52 WEEK HIGH
282.15
52 WEEK LOW
186.05
MARKET CAP
15.09B
P/E (TTM)
18.10
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ASND last week (0928-1002)?
Weekly Report · 23h ago
Analysts Are Bullish on These Healthcare Stocks: Ascendis Pharma (ASND), Cytokinetics (CYTK)
TipRanks · 2d ago
Here's How Much $1000 Invested In Ascendis Pharma 10 Years Ago Would Be Worth Today
Benzinga · 5d ago
BioMarin Pharmaceutical Inks License Deal With Ascendis Pharma; Grants Ascendis License For Transcon Cnp, Navepegritide, Yuviwel; Ascendis To Pay Biomarin 20% U.S., 18% EU/Br/Sk Royalty On Sales Until May 2030; All Pending Litigation Dismissed
Benzinga · 5d ago
Barclays Reaffirms Their Buy Rating on Ascendis Pharma (ASND)
TipRanks · 5d ago
Ascendis Pharma Closes Warrant Exercise Window, Lifts Share Capital on September 29, 2026
TipRanks · 6d ago
Cantor Fitzgerald Remains a Buy on Ascendis Pharma (ASND)
TipRanks · 09/28 12:36
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ascendis Pharma (ASND), Lakefront Biotherapeutics (LKFT) and 10x Genomics (TXG)
TipRanks · 09/28 12:30
More
About ASND
Ascendis Pharma A/S is a Denmark‑based biopharmaceutical company operating within the life sciences and biotechnology sector. The Company scope of activity includes discovery, development, and commercialization of innovative therapies for rare diseases and serious chronic conditions with significant unmet medical needs where a clinically validated parent drug or pathway is suitable to company technologies. Ascendis Pharma A/S focuses on the endocrinology area and has a pipeline of three independent rare disease product candidates, such as Growth Hormone Deficiency (GHD), Hypoparathyroidism and Achondroplasia. The second therapeutic area is oncology, where the company focuses immunotherapy to targeted therapies.

Webull offers Ascendis Pharma A/S stock information, including NASDAQ: ASND real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ASND stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ASND stock methods without spending real money on the virtual paper trading platform.